Primary health care for patients with alcohol use disorders

被引:0
作者
Maynie-Francois, Christine [1 ]
Dupouy, Julie [2 ]
机构
[1] Univ Lyon, Univ Claude Bernard Lyon 1, Coll Univ Med Gen, 8 Ave Rockefeller, F-69008 Lyon, France
[2] Univ Toulouse III Paul Sabatier, Dept Univ Med Gen, 118 Route Narbonne, F-31062 Toulouse, France
来源
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE | 2019年 / 152期
关键词
alcoholism; alchol-related disorders; primary health care; drug therapy; HIGH-DOSE BACLOFEN; DEPENDENCE; MANAGEMENT; CONSUMPTION; NALMEFENE; DRINKING; INTERVENTIONS; METAANALYSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. In France, alcohol represents the second cause of avoidable death after smoking. One in three adults has at-risk alcohol use (AAU). General practitioners (GP) are at the front line for screening and providing appropriate care for patients with AAU. This article provides a critical review of screening methods and health care solutions for patients with MU in primary care. Screening and diagnosis of alcohol use disorders (AUDS). Alcohol consumption should be characterized with an evaluation of the number of drinks per day and per occasion, and the patient's context. Primary care validated questionnaires such as the AUDIT-C or the CAGE can be used. An associated AUD can be diagnosed using DSM-5 criteria. Screening and Brief Intervention (SBI). SBI is an intervention protocol internationally recommended to screen for at-risk alcohol use. Its efficacy has been proven only for at-risk alcohol use without AUD. The evidence regarding SBI efficacy is of moderate quality. The main outcome is always self-reported alcohol use, with no clinical outcome. What should GPs do with patients with AUDs? Non pharmacological tools such as motivational interviewing have shown efficacy in primary care. Some medications are available, such as acamprosate and naltrexone to help maintain abstinence, nalmefene to reduce alcohol consumption, or baclofen on temporary use. The evidence regarding their efficacy is of low quality and their effect is moderate. Conclusion. Screening tools and treatment options exist that can be used in primary care by GPs to help their patients with AAU. Their efficacy is moderate and evidence regarding this efficacy is of low quality, but while research improves, they represent treatment options for GPs. Research on AUDs to help develop high quality evidence for health problems they are on the front line to screen and care for would be helpful.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 53 条
[1]  
Abdelnour X, 2017, THESIS
[2]  
Agence nationale d'accreditation et d'evaluation en sante, 2013, C CONS OBJ IND MOD S
[3]  
Agence nationale de securite du medicament et des produits de sante, 2017, RTU BACL ALC DEP REN
[4]  
Agence nationale de securite du medicament et des produits de sante, 2018, RES CAR PROD BACL CO
[5]  
Agence nationale de securite du medicament et des produits de sante, 2016, RES ET US SEC BACL F
[6]   Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: A self-case report of a physician [J].
Ameisen, O .
ALCOHOL AND ALCOHOLISM, 2005, 40 (02) :147-150
[7]  
[Anonymous], 2000, DIAGNOSTIC STAT MANU
[8]  
[Anonymous], OUT AID REP PREC INT
[9]  
[Anonymous], 2011, PRESCRIRE, V31, P837
[10]  
[Anonymous], 2006, COCHRANE DATABASE SY